Asher Raises $55 Million Series A for Targeted Cancer Immunotherapies

Retrieved on: 2021-03-23 18:45:00

Tags for this article:

Click the tags to see associated articles and topics

Asher Raises $55 Million Series A for Targeted Cancer Immunotherapies. View article details on hiswai:

Excerpt

Targeted immunotherapy company Asher Bio launched today with a $55 million Series A round led by Third Rock Ventures, aiming to move its lead ...

Article found on: www.biospace.com